Description:

Amgen Inc. (AMGN) is a multinational biotechnology corporation headquartered in Thousand Oaks, California. It is one of the largest independent biotechnology companies in the world. The company was founded in 1980 and is listed on the New York Stock Exchange (NYSE). Amgen is known for its innovative approach to developing and commercializing therapies for serious diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. The company's product pipeline includes a range of biologics and small molecule therapies, and it has established partnerships with various pharmaceutical companies to develop and commercialize its products. As of my knowledge cutoff, Amgen's stock price is subject to fluctuations in the market, and its financial performance is influenced by various factors, including the success of its product pipeline and regulatory approvals.

Data:

Yields: